Form 8-K - Current report:
SEC Accession No. 0001558370-22-017015
Filing Date
2022-11-09
Accepted
2022-11-09 07:45:42
Documents
52
Period of Report
2022-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xlo-20221109x8k.htm   iXBRL 8-K 55065
2 EX-99.1 xlo-20221109xex99d1.htm EX-99.1 141675
3 EX-99.2 xlo-20221109xex99d2.htm EX-99.2 68359
4 GRAPHIC xlo-20221109xex99d1001.jpg GRAPHIC 1190
5 GRAPHIC xlo-20221109xex99d2g028.jpg GRAPHIC 188992
6 GRAPHIC xlo-20221109xex99d2g036.jpg GRAPHIC 205105
7 GRAPHIC xlo-20221109xex99d2g007.jpg GRAPHIC 173993
8 GRAPHIC xlo-20221109xex99d2g012.jpg GRAPHIC 184247
9 GRAPHIC xlo-20221109xex99d2g030.jpg GRAPHIC 113409
10 GRAPHIC xlo-20221109xex99d2g027.jpg GRAPHIC 145623
11 GRAPHIC xlo-20221109xex99d2g022.jpg GRAPHIC 172616
12 GRAPHIC xlo-20221109xex99d2g033.jpg GRAPHIC 92522
13 GRAPHIC xlo-20221109xex99d2g031.jpg GRAPHIC 138217
14 GRAPHIC xlo-20221109xex99d2g025.jpg GRAPHIC 153793
15 GRAPHIC xlo-20221109xex99d2g017.jpg GRAPHIC 220661
16 GRAPHIC xlo-20221109xex99d2g011.jpg GRAPHIC 119791
17 GRAPHIC xlo-20221109xex99d2g013.jpg GRAPHIC 200893
18 GRAPHIC xlo-20221109xex99d2g021.jpg GRAPHIC 189600
19 GRAPHIC xlo-20221109xex99d2g002.jpg GRAPHIC 364426
20 GRAPHIC xlo-20221109xex99d2g001.jpg GRAPHIC 154522
21 GRAPHIC xlo-20221109xex99d2g019.jpg GRAPHIC 257229
22 GRAPHIC xlo-20221109xex99d2g010.jpg GRAPHIC 100578
23 GRAPHIC xlo-20221109xex99d2g018.jpg GRAPHIC 170106
24 GRAPHIC xlo-20221109xex99d2g008.jpg GRAPHIC 205909
25 GRAPHIC xlo-20221109xex99d2g014.jpg GRAPHIC 207668
26 GRAPHIC xlo-20221109xex99d2g006.jpg GRAPHIC 134244
27 GRAPHIC xlo-20221109xex99d2g024.jpg GRAPHIC 217642
28 GRAPHIC xlo-20221109xex99d2g016.jpg GRAPHIC 185645
29 GRAPHIC xlo-20221109xex99d2g020.jpg GRAPHIC 112285
30 GRAPHIC xlo-20221109xex99d2g009.jpg GRAPHIC 144482
31 GRAPHIC xlo-20221109xex99d2g003.jpg GRAPHIC 220797
32 GRAPHIC xlo-20221109xex99d2g023.jpg GRAPHIC 134170
33 GRAPHIC xlo-20221109xex99d2g029.jpg GRAPHIC 192801
34 GRAPHIC xlo-20221109xex99d2g034.jpg GRAPHIC 157675
35 GRAPHIC xlo-20221109xex99d2g005.jpg GRAPHIC 122241
36 GRAPHIC xlo-20221109xex99d2g035.jpg GRAPHIC 133499
37 GRAPHIC xlo-20221109xex99d2g037.jpg GRAPHIC 136517
38 GRAPHIC xlo-20221109xex99d2g026.jpg GRAPHIC 201027
39 GRAPHIC xlo-20221109xex99d2g004.jpg GRAPHIC 204550
40 GRAPHIC xlo-20221109xex99d2g015.jpg GRAPHIC 112630
41 GRAPHIC xlo-20221109xex99d2g032.jpg GRAPHIC 193414
  Complete submission text file 0001558370-22-017015.txt   9194465

Data Files

Seq Description Document Type Size
42 EX-101.SCH xlo-20221109.xsd EX-101.SCH 3114
43 EX-101.LAB xlo-20221109_lab.xml EX-101.LAB 16578
44 EX-101.PRE xlo-20221109_pre.xml EX-101.PRE 10708
46 EXTRACTED XBRL INSTANCE DOCUMENT xlo-20221109x8k_htm.xml XML 5045
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

EIN.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40925 | Film No.: 221370688
SIC: 2834 Pharmaceutical Preparations